Autolus Therapeutics Email Format
Biotechnology ResearchEngland, United Kingdom501-1000 Employees
Autolus Therapeutics is a London-based biotechnology company focused on autologous T cell therapies, including CAR T cell approaches. The company uses programmable T cell technologies to develop next-generation therapies intended to treat cancer and autoimmune diseases. It operates as a commercial-stage biopharmaceutical company involved in the development, manufacturing, and delivery of programmed T cell therapies and candidates. The organization employs an estimated 501 to 1000 people and is located in London, England, United Kingdom, with postal code W12 7RZ. In 2026, Autolus was recognized with the Prix Galien UK Award for Best Biotechnology Product and announced clinical data updates related to the ASCO Annual Meeting.